Lisata Therapeutics, Inc.
General ticker "LSTA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $26.7M (TTM average)
Lisata Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -11.6%.
Estimated limits based on current volatility of 10.2%: low 1.43$, high 1.75$
Factors to consider:
- Total employees count: 21 (-19.2%) as of 2025
- Top business risk factors: Operational and conduct risks, Acquisition/divestiture risks, Regulatory and compliance, Manufacturing supply issues, Market acceptance
- Earnings for 6 months up through Q2 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.14$, 3.07$]
- 2026-12-31 to 2027-12-31 estimated range: [1.01$, 2.77$]
Financial Metrics affecting the LSTA estimates:
- Positive: with PPE of -0.9 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -92.52 <= 0.28
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Investing cash flow per share per price, % of 87.52 > -0.64
- Positive: Shareholder equity ratio, % of 83.72 > 63.63
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term LSTA quotes
Long-term LSTA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $1.00MM | $0.17MM |
| Operating Expenses | $25.71MM | $23.41MM | $18.38MM |
| Operating Income | $-25.71MM | $-22.41MM | $-18.21MM |
| Non-Operating Income | $2.54MM | $1.63MM | $0.66MM |
| R&D Expense | $12.73MM | $11.33MM | $7.95MM |
| Income(Loss) | $-23.17MM | $-20.78MM | $-17.55MM |
| Taxes | $-2.33MM | $-0.80MM | $-0.96MM |
| Net Income(Loss)* | $-20.84MM | $-19.98MM | $-16.59MM |
| Stockholders Equity | $48.15MM | $29.57MM | $14.86MM |
| Assets | $54.69MM | $35.00MM | $17.74MM |
| Operating Cash Flow | $-20.03MM | $-19.36MM | $-15.95MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.03MM |
| Investing Cash Flow | $10.10MM | $13.23MM | $15.09MM |
| Financing Cash Flow | $0.39MM | $-0.21MM | $0.60MM |
| Earnings Per Share** | $-2.58 | $-2.40 | $-1.91 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.